Dogs to explain human retinal disease?

Article

A genetic mutation that is associated with recessive cone-rod dystrophy in dachshunds may play the same role in humans, according to a study in the August 2008 issue of Genome Research.

A genetic mutation that is associated with recessive cone-rod dystrophy in dachshunds may play the same role in humans, according to a study in the August 2008 issue of Genome Research.

Dr Frode Lingaas of the Department of Basic Sciences and Aquatic Medicine at the Norwegian School of Veterinary Science, Oslo, Norway, and colleagues performed genome-wide association-based Sibling Transmission Disequilibrium Test (sibTDT) analysis to identify and then resequence an area on canine chromosome 5, which contains more than 70 genes.

The analysis showed that, in dachshunds suffering from cone-rod dystrophy, one gene - nephronophthisis/nephroretinin 4 (NPHP4) - had an area missing, which produced a truncated protein that interferes with interaction in the eye but not the kidney (NPHP4's other biological target).

The team concluded that this mutation, the truncated protein produced by NPHP4, is responsible for the development of cone-rod dystrophy in a canine model. As other NPHP4 mutations have been associated with eye and kidney disease in humans, the team speculate that further investigation of this mutation could result in an explanation for similar degenerative retinal diseases in humans.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
Related Content
© 2025 MJH Life Sciences

All rights reserved.